The XVII Russian Congress "Innovative Technologies in Pediatrics and Pediatric Surgery" was held in Moscow in late October with the support of the Valenta Pharm. The scientific program of the congress included more than 30 plenary sessions, symposiums, and lectures, which addressed various topical issues in many pediatric fields. The event was attended by more than 400 doctors of various specialties from Russia, France, USA, Poland and neighboring countries.
During the congress, two highly specialized symposiums on acute respiratory viral diseases and their impact on the development of otorhinolaryngological complications in children were organized.
Elena Gennadyevna Kondyurina, dr. med. habíl, Professor, Head of Pediatrics, Faculty of Advanced Training and Professional Retraining of Doctors, Novosibirsk State Medical University, chaired a symposium "Acute Respiratory Viral Diseases: Current Issues of Treatment and Prevention." Leading experts Alexander Borisovich Malakhov, dr. med. habíl, Professor, senior external children's pulmonologist of Moscow Healthcare Department and Andrey Yurievich Egorov, Doctor of Biological Sciences, Professor, University of Natural Resources and Life Sciences, Vienna, Austria presented their reports at the symposium. The following topics were presented: phases of the infection process development in acute respiratory viral infections, the role of antiviral drugs groups in treatment of respiratory viral infections in children, the unique mechanism of action of the antiviral drug Ingavirin®.
The symposium “Discussion Club: Otorhinolaryngological Complications of ARVI in Children: a Problem for Pediatricians, ENT specialists or Infectiologists?” chaired by Mikhail Rafailovich Bogomilsky, Corresponding Member, Russian Academy of Sciences, Honored Worker of Science of the Russian Federation, dr. med. habíl, Professor, Head of Pediatric Otorhinolaryngology, Pirogov Russian National Research Medical University, touched upon the treatment of common diseases in children, such as: inflammation of the oropharynx (adenoiditis, pharyngitis, tonsillopharyngitis), herpes viral infections. Symposium participants discussed modern methods and trends of treatment, including international experience, and noted the importance of the introduction of original, innovative drugs for the treatment of children.
Elena Yuryevna Radtsig, dr. med. habíl, Professor, Head of Otorhinolaryngology, Pirogov Russian National Research Medical University, noted that: “We live in a time when the drugs used in pediatric practice are becoming less and less numerous. It is very important that for the treatment of infectious and inflammatory diseases of the oropharynx in children we still have a drug such as Grammidin® for children, including in the form of a spray”.
“The introduction of new original drugs with a favorable safety profile and high efficacy is extremely important, especially in pediatrics. Valenta Pharm is actively working in this direction, investing in the development of new drugs and drug forms. Having launched Grammidin® Spray Kids earlier this year, the company introduced to the Russian pharmaceutical market a new convenient dosage form for children from the age of 6. Valenta Pharm offered patients and the pediatric community the only drug in the form of a spray for the treatment of infectious and inflammatory diseases of the pharynx, containing a combination of local antibiotic and antiseptic", said Lesya Anfinogenova, Group Product Manager, Anti-Cold Medicines business unit, Valenta Pharm.